Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry

Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

(2013) Ryu Matsuo et al.   BMC Neurology

Proteinuria and clinical outcomes after ischemic stroke

(2012) Y. Kumai et al.   NEUROLOGY

Outcome of Acute Ischemic Stroke in Very Elderly Patients: Is Intravenous Thrombolysis Beneficial?

(2011) Pi-Shan Sung et al.   EUROPEAN NEUROLOGY

Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke

(2011) Masahiro Kamouchi et al.   STROKE

Low-Dose Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy for Patients With Stroke Outside European Indications

(2011) Masatoshi Koga et al.   STROKE

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Ischemic stroke in the elderly: an overview of evidence

(2010) Ruo-Li Chen et al.   Nature Reviews Neurology

Is Thrombolysis Safe in the Elderly?

(2010) Amer Alshekhlee et al.   STROKE

Intravenous Alteplase for Stroke in Those Older Than 80 Years Old

(2010) Gary A. Ford et al.   STROKE

Pharmacotherapy for the Secondary Prevention of Stroke

(2009) Kazunori Toyoda   DRUGS

The response to IV rt-PA in very old stroke patients

(2008) M. Gómez-Choco et al.   EUROPEAN JOURNAL OF NEUROLOGY

Outline of the Japanese Guidelines for the Management of Stroke 2004 and Subsequent Revision

(2008) Yukito Shinohara et al.   International Journal of Stroke

APOE genotype, ethnicity, and the risk of cerebral hemorrhage

(2008) C. Tzourio et al.   NEUROLOGY

Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial

(2008) Mei Yong et al.   STROKE